SlideShare a Scribd company logo
Sepsis hemodynamic update
part two
Dr. Mohammed Abdelaziz Salim
ICU physician
Meeqat General Hospital
 Sepsis is a potentially life-threatening
condition that occurs when the body
response to an infection damage its own
tissue.
 When the infection fighting processes turn
on the body they cause organs to function
poorly and abnormally.
 Sepsis may progress to septic shock.
 This is a dramatic drop in blood pressure
that can lead to sever organ problems and
death.
Mean arterial pressure
9- For adults with septic shock on
vasopressors, we recommend an initial
target mean arterial pressure (MAP) of 65
mm Hg over higher MAP targets.
Strong recommendation
Fluid management
32- For adult with sepsis or septic shock we recommend using crystalloids as first
line fluid for resuscitation. (strong recommendation)
33- For adults with sepsis or septic shock we suggest using balanced crystalloids
instead of NS of resuscitation. (weak recommendation)
34- For adults with sepsis or septic shock we suggest using albumin in patient
who receive large volume of crystalloids over using crystalloids alone.
35- For adults with sepsis or septic shock we recommend against using starches
for resuscitation. (strong recommendation)
36- For adults with sepsis or septic shock we suggest against using gelatin for
resuscitation. (weak recommendation)
Fluid balance
 There is insufficient evidence to make a
recommendation on the use of restrictive versus
liberal fluid strategies in the first 24 hrs. of
resuscitation in patient with sepsis or septic shock
who still have signs of hypoperfusion and volume
depletion after initial resuscitation.
 Fluid resuscitation should be given only if patient
present with signs of hypoperfusion
Vasoactive Agent Management
37-For adult with septic shock we recommend using norepinephrine as the first
line agent over other vasopressors. ( strong recommendation)
 Dopamine. (High quality evidence)
 Vasopressin. (Moderate quality evidence)
 Epinephrine. (Low quality evidence)
 Selepressin. (Low quality evidence)
 Angiotensin II. (Very low quality evidence)
Notes:
 In case of norepinephrine is not available, epinephrine or dopamine can be
used as alternative, but we encourage efforts to improve availability of
norepinephrine.
 Special attention should be given to patients at risk for arrhythmias
 38- For adults with septic shock on norepinephrine with inadequate MAP level
we suggest adding vasopressin instead of escalating the dose of
norepinephrine. ( weak recommendation)
 In ICU practice vasopressin usually started when the dose of norepinephrine
is in the range of 0.25 – 0.5 ug/kg/min.
 39- For adults with septic shock and inadequate MAP level despite
norepinephrine and vasopressin we suggest adding epinephrine.
(weak recommendation)
 40- For adults with septic shock we suggest against using terlipressin.
(weak recommendation)
 41- For adults with septic shock and cardiac dysfunction with
persistent hypoperfusion despite adequate volume state and
arterial blood pressure we suggest either adding dobutamine to
norepinephrine or using epinephrine alone.
(weak recommendation)
 42- For adults with septic shock and cardiac dysfunction with
persistent hypoperfusion despite adequate volume status and
arterial blood pressure we suggest against using levosimendan.
(weak recommendation)
Monitoring and intravenous access
 43- For adults with septic shock we suggest using invasive monitoring of
arterial pressure over non invasive monitoring.
(weak recommendation)
 44- For adults with septic shock we suggest starting vasopressors peripherally
to restore MAP rather than delaying initiation until a central access is
secured.
(weak recommendation)
 Notes :
When using vasopressors peripherally they should be administered only for
short period of time and in a vein in or proximal to the antecubital fossa ..
Sepsis hemodynamic update      part two
Sepsis hemodynamic update      part two
Sepsis hemodynamic update      part two

More Related Content

What's hot (20)

Sepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis GuidelinesSepsis, Septic Shock and Surviving Sepsis Guidelines
Sepsis, Septic Shock and Surviving Sepsis Guidelines
 
Sepsis In critical care 2019 final
Sepsis In critical care 2019 finalSepsis In critical care 2019 final
Sepsis In critical care 2019 final
 
Sepsis 3.0
Sepsis 3.0Sepsis 3.0
Sepsis 3.0
 
Sepsis And Septic Shock
Sepsis And Septic ShockSepsis And Septic Shock
Sepsis And Septic Shock
 
The STOP Sepsis Bundle
The STOP Sepsis BundleThe STOP Sepsis Bundle
The STOP Sepsis Bundle
 
CME: Management of Severe Sepsis & Septic Shock
CME: Management of Severe Sepsis & Septic ShockCME: Management of Severe Sepsis & Septic Shock
CME: Management of Severe Sepsis & Septic Shock
 
Sepsis
SepsisSepsis
Sepsis
 
Sepsis 3
Sepsis 3Sepsis 3
Sepsis 3
 
Resuscitation Fluids
Resuscitation FluidsResuscitation Fluids
Resuscitation Fluids
 
Management of sepsis and septic shock
Management of sepsis and septic shockManagement of sepsis and septic shock
Management of sepsis and septic shock
 
Sepsis 2017
Sepsis 2017Sepsis 2017
Sepsis 2017
 
Sepsis
SepsisSepsis
Sepsis
 
SEPSIS PPT 2.pptx
SEPSIS PPT 2.pptxSEPSIS PPT 2.pptx
SEPSIS PPT 2.pptx
 
Sepsis resuscitation bundle
Sepsis resuscitation bundleSepsis resuscitation bundle
Sepsis resuscitation bundle
 
Sepsis scoring
Sepsis  scoringSepsis  scoring
Sepsis scoring
 
Fluid management in ICU
Fluid management in ICUFluid management in ICU
Fluid management in ICU
 
Surviving Sepsis Guidelines 2012
Surviving Sepsis Guidelines 2012Surviving Sepsis Guidelines 2012
Surviving Sepsis Guidelines 2012
 
The four phases of intravenous fluid therapy: Manu Malbrain
The four phases of intravenous fluid therapy: Manu MalbrainThe four phases of intravenous fluid therapy: Manu Malbrain
The four phases of intravenous fluid therapy: Manu Malbrain
 
Sepsis guidelines
Sepsis guidelinesSepsis guidelines
Sepsis guidelines
 
Sepsis
SepsisSepsis
Sepsis
 

Similar to Sepsis hemodynamic update part two

New sepsis guidelines.pptx...mmmmmmmmmmm
New sepsis guidelines.pptx...mmmmmmmmmmmNew sepsis guidelines.pptx...mmmmmmmmmmm
New sepsis guidelines.pptx...mmmmmmmmmmmToqeerHussain22
 
Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)SoM
 
Article presentation / Surviving sepsis campaign: international guidelines fo...
Article presentation / Surviving sepsis campaign: international guidelines fo...Article presentation / Surviving sepsis campaign: international guidelines fo...
Article presentation / Surviving sepsis campaign: international guidelines fo...FaisalRawagah1
 
Presentation of alteplase drugs
Presentation of alteplase drugsPresentation of alteplase drugs
Presentation of alteplase drugsRakibulHussain1
 
aplastic anemia power point presentation
aplastic anemia  power point presentationaplastic anemia  power point presentation
aplastic anemia power point presentationmitalipatter
 
Current Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptxCurrent Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptxHoKimWah
 
SIRS and SEPSIS_2.pptx Dr Nannika Pradhan
SIRS and SEPSIS_2.pptx Dr Nannika PradhanSIRS and SEPSIS_2.pptx Dr Nannika Pradhan
SIRS and SEPSIS_2.pptx Dr Nannika Pradhannainnu81
 
Current Recommendations and Changes From Previous 2016 Recommendations.pptx
Current Recommendations and Changes From Previous 2016 Recommendations.pptxCurrent Recommendations and Changes From Previous 2016 Recommendations.pptx
Current Recommendations and Changes From Previous 2016 Recommendations.pptxAshishSharma907946
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015samirelansary
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015samirelansary
 
Plasma pharesis in neurological disorders
Plasma pharesis in neurological disorders Plasma pharesis in neurological disorders
Plasma pharesis in neurological disorders NeurologyKota
 
Primary Adrenal Insufficiency
Primary Adrenal InsufficiencyPrimary Adrenal Insufficiency
Primary Adrenal InsufficiencyAmer Alboush
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disordermadhu sunkara
 
Approach to Chest pain
Approach to Chest pain Approach to Chest pain
Approach to Chest pain ahm732
 

Similar to Sepsis hemodynamic update part two (20)

New sepsis guidelines.pptx...mmmmmmmmmmm
New sepsis guidelines.pptx...mmmmmmmmmmmNew sepsis guidelines.pptx...mmmmmmmmmmm
New sepsis guidelines.pptx...mmmmmmmmmmm
 
Vasoactive medications
Vasoactive medicationsVasoactive medications
Vasoactive medications
 
Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)Room a b01. mcgee-new sepsis_(en)
Room a b01. mcgee-new sepsis_(en)
 
Article presentation / Surviving sepsis campaign: international guidelines fo...
Article presentation / Surviving sepsis campaign: international guidelines fo...Article presentation / Surviving sepsis campaign: international guidelines fo...
Article presentation / Surviving sepsis campaign: international guidelines fo...
 
Presentation of alteplase drugs
Presentation of alteplase drugsPresentation of alteplase drugs
Presentation of alteplase drugs
 
aplastic anemia power point presentation
aplastic anemia  power point presentationaplastic anemia  power point presentation
aplastic anemia power point presentation
 
Current Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptxCurrent Strategy in Management of Severe Sepsis.pptx
Current Strategy in Management of Severe Sepsis.pptx
 
Emergency Medicine Notes 2019
Emergency Medicine Notes 2019Emergency Medicine Notes 2019
Emergency Medicine Notes 2019
 
SIRS and SEPSIS_2.pptx Dr Nannika Pradhan
SIRS and SEPSIS_2.pptx Dr Nannika PradhanSIRS and SEPSIS_2.pptx Dr Nannika Pradhan
SIRS and SEPSIS_2.pptx Dr Nannika Pradhan
 
Current Recommendations and Changes From Previous 2016 Recommendations.pptx
Current Recommendations and Changes From Previous 2016 Recommendations.pptxCurrent Recommendations and Changes From Previous 2016 Recommendations.pptx
Current Recommendations and Changes From Previous 2016 Recommendations.pptx
 
Sepsis guideline 2021.pptx
Sepsis guideline 2021.pptxSepsis guideline 2021.pptx
Sepsis guideline 2021.pptx
 
Sepsis Treatment
Sepsis TreatmentSepsis Treatment
Sepsis Treatment
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015
 
Plasma pharesis in neurological disorders
Plasma pharesis in neurological disorders Plasma pharesis in neurological disorders
Plasma pharesis in neurological disorders
 
Vasopressors in Sepsis
Vasopressors in SepsisVasopressors in Sepsis
Vasopressors in Sepsis
 
Primary Adrenal Insufficiency
Primary Adrenal InsufficiencyPrimary Adrenal Insufficiency
Primary Adrenal Insufficiency
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disorder
 
Antiphospholipid Syndrome
Antiphospholipid SyndromeAntiphospholipid Syndrome
Antiphospholipid Syndrome
 
Approach to Chest pain
Approach to Chest pain Approach to Chest pain
Approach to Chest pain
 

More from MEEQAT HOSPITAL

Updated conscious sedation course.ppt
Updated conscious sedation course.pptUpdated conscious sedation course.ppt
Updated conscious sedation course.pptMEEQAT HOSPITAL
 
Updated algorithm of ER – ICU - In - patients guidelines.pptx
Updated algorithm of ER – ICU -  In - patients guidelines.pptxUpdated algorithm of ER – ICU -  In - patients guidelines.pptx
Updated algorithm of ER – ICU - In - patients guidelines.pptxMEEQAT HOSPITAL
 
Blood Bank Lecture .pptx
Blood Bank Lecture .pptxBlood Bank Lecture .pptx
Blood Bank Lecture .pptxMEEQAT HOSPITAL
 
Medication error, nursing responsibility
Medication error, nursing responsibilityMedication error, nursing responsibility
Medication error, nursing responsibilityMEEQAT HOSPITAL
 
Continuous renal replacement therapy crrt
Continuous renal replacement therapy crrtContinuous renal replacement therapy crrt
Continuous renal replacement therapy crrtMEEQAT HOSPITAL
 
Deep venous thrombosis dvt
Deep venous thrombosis dvtDeep venous thrombosis dvt
Deep venous thrombosis dvtMEEQAT HOSPITAL
 
Chest intubation indications,precautions and management
Chest intubation indications,precautions and managementChest intubation indications,precautions and management
Chest intubation indications,precautions and managementMEEQAT HOSPITAL
 
Covid19 corona management -كوفيد19
Covid19 corona management -كوفيد19Covid19 corona management -كوفيد19
Covid19 corona management -كوفيد19MEEQAT HOSPITAL
 
Conscious sedation course
Conscious sedation courseConscious sedation course
Conscious sedation courseMEEQAT HOSPITAL
 
Medical permission for patient
Medical permission for patientMedical permission for patient
Medical permission for patientMEEQAT HOSPITAL
 
Isolation precautions in hospitals covid19
Isolation precautions in hospitals covid19Isolation precautions in hospitals covid19
Isolation precautions in hospitals covid19MEEQAT HOSPITAL
 
Line tracing & line reconciliation
Line tracing & line reconciliationLine tracing & line reconciliation
Line tracing & line reconciliationMEEQAT HOSPITAL
 
Medication administration
Medication administrationMedication administration
Medication administrationMEEQAT HOSPITAL
 
Risk management intruduction part 1
Risk management intruduction  part 1Risk management intruduction  part 1
Risk management intruduction part 1MEEQAT HOSPITAL
 

More from MEEQAT HOSPITAL (20)

Updated conscious sedation course.ppt
Updated conscious sedation course.pptUpdated conscious sedation course.ppt
Updated conscious sedation course.ppt
 
fatal asthma.pptx
fatal asthma.pptxfatal asthma.pptx
fatal asthma.pptx
 
Updated algorithm of ER – ICU - In - patients guidelines.pptx
Updated algorithm of ER – ICU -  In - patients guidelines.pptxUpdated algorithm of ER – ICU -  In - patients guidelines.pptx
Updated algorithm of ER – ICU - In - patients guidelines.pptx
 
Blood Bank Lecture .pptx
Blood Bank Lecture .pptxBlood Bank Lecture .pptx
Blood Bank Lecture .pptx
 
Post covid -19 syndrome
Post covid -19 syndromePost covid -19 syndrome
Post covid -19 syndrome
 
Medication error, nursing responsibility
Medication error, nursing responsibilityMedication error, nursing responsibility
Medication error, nursing responsibility
 
Continuous renal replacement therapy crrt
Continuous renal replacement therapy crrtContinuous renal replacement therapy crrt
Continuous renal replacement therapy crrt
 
Deep venous thrombosis dvt
Deep venous thrombosis dvtDeep venous thrombosis dvt
Deep venous thrombosis dvt
 
Bed sore management
Bed sore managementBed sore management
Bed sore management
 
Chest intubation indications,precautions and management
Chest intubation indications,precautions and managementChest intubation indications,precautions and management
Chest intubation indications,precautions and management
 
Portable ventilator
Portable ventilatorPortable ventilator
Portable ventilator
 
Covid19 corona management -كوفيد19
Covid19 corona management -كوفيد19Covid19 corona management -كوفيد19
Covid19 corona management -كوفيد19
 
Sedation
SedationSedation
Sedation
 
Conscious sedation course
Conscious sedation courseConscious sedation course
Conscious sedation course
 
Electronic medica file
Electronic medica fileElectronic medica file
Electronic medica file
 
Medical permission for patient
Medical permission for patientMedical permission for patient
Medical permission for patient
 
Isolation precautions in hospitals covid19
Isolation precautions in hospitals covid19Isolation precautions in hospitals covid19
Isolation precautions in hospitals covid19
 
Line tracing & line reconciliation
Line tracing & line reconciliationLine tracing & line reconciliation
Line tracing & line reconciliation
 
Medication administration
Medication administrationMedication administration
Medication administration
 
Risk management intruduction part 1
Risk management intruduction  part 1Risk management intruduction  part 1
Risk management intruduction part 1
 

Recently uploaded

Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptSourabh Kumar
 
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...Nguyen Thanh Tu Collection
 
How to Manage Notification Preferences in the Odoo 17
How to Manage Notification Preferences in the Odoo 17How to Manage Notification Preferences in the Odoo 17
How to Manage Notification Preferences in the Odoo 17Celine George
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfjoachimlavalley1
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePedroFerreira53928
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfQucHHunhnh
 
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya - UEM Kolkata Quiz Club
 
Open Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPointOpen Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPointELaRue0
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticspragatimahajan3
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...Nguyen Thanh Tu Collection
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaasiemaillard
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxbennyroshan06
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxShibin Azad
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptxmansk2
 
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxJose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxricssacare
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345beazzy04
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportAvinash Rai
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaasiemaillard
 

Recently uploaded (20)

Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.pptBasic_QTL_Marker-assisted_Selection_Sourabh.ppt
Basic_QTL_Marker-assisted_Selection_Sourabh.ppt
 
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
50 ĐỀ LUYỆN THI IOE LỚP 9 - NĂM HỌC 2022-2023 (CÓ LINK HÌNH, FILE AUDIO VÀ ĐÁ...
 
How to Manage Notification Preferences in the Odoo 17
How to Manage Notification Preferences in the Odoo 17How to Manage Notification Preferences in the Odoo 17
How to Manage Notification Preferences in the Odoo 17
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdfDanh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
Danh sách HSG Bộ môn cấp trường - Cấp THPT.pdf
 
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General QuizPragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
Pragya Champions Chalice 2024 Prelims & Finals Q/A set, General Quiz
 
Open Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPointOpen Educational Resources Primer PowerPoint
Open Educational Resources Primer PowerPoint
 
size separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceuticssize separation d pharm 1st year pharmaceutics
size separation d pharm 1st year pharmaceutics
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
Mattingly "AI & Prompt Design: Limitations and Solutions with LLMs"
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Gyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptxGyanartha SciBizTech Quiz slideshare.pptx
Gyanartha SciBizTech Quiz slideshare.pptx
 
2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx2024_Student Session 2_ Set Plan Preparation.pptx
2024_Student Session 2_ Set Plan Preparation.pptx
 
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptxJose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
Jose-Rizal-and-Philippine-Nationalism-National-Symbol-2.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Industrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training ReportIndustrial Training Report- AKTU Industrial Training Report
Industrial Training Report- AKTU Industrial Training Report
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Introduction to Quality Improvement Essentials
Introduction to Quality Improvement EssentialsIntroduction to Quality Improvement Essentials
Introduction to Quality Improvement Essentials
 

Sepsis hemodynamic update part two

  • 1. Sepsis hemodynamic update part two Dr. Mohammed Abdelaziz Salim ICU physician Meeqat General Hospital
  • 2.  Sepsis is a potentially life-threatening condition that occurs when the body response to an infection damage its own tissue.  When the infection fighting processes turn on the body they cause organs to function poorly and abnormally.  Sepsis may progress to septic shock.  This is a dramatic drop in blood pressure that can lead to sever organ problems and death.
  • 3. Mean arterial pressure 9- For adults with septic shock on vasopressors, we recommend an initial target mean arterial pressure (MAP) of 65 mm Hg over higher MAP targets. Strong recommendation
  • 4. Fluid management 32- For adult with sepsis or septic shock we recommend using crystalloids as first line fluid for resuscitation. (strong recommendation) 33- For adults with sepsis or septic shock we suggest using balanced crystalloids instead of NS of resuscitation. (weak recommendation) 34- For adults with sepsis or septic shock we suggest using albumin in patient who receive large volume of crystalloids over using crystalloids alone. 35- For adults with sepsis or septic shock we recommend against using starches for resuscitation. (strong recommendation) 36- For adults with sepsis or septic shock we suggest against using gelatin for resuscitation. (weak recommendation)
  • 5. Fluid balance  There is insufficient evidence to make a recommendation on the use of restrictive versus liberal fluid strategies in the first 24 hrs. of resuscitation in patient with sepsis or septic shock who still have signs of hypoperfusion and volume depletion after initial resuscitation.  Fluid resuscitation should be given only if patient present with signs of hypoperfusion
  • 6.
  • 7. Vasoactive Agent Management 37-For adult with septic shock we recommend using norepinephrine as the first line agent over other vasopressors. ( strong recommendation)  Dopamine. (High quality evidence)  Vasopressin. (Moderate quality evidence)  Epinephrine. (Low quality evidence)  Selepressin. (Low quality evidence)  Angiotensin II. (Very low quality evidence) Notes:  In case of norepinephrine is not available, epinephrine or dopamine can be used as alternative, but we encourage efforts to improve availability of norepinephrine.  Special attention should be given to patients at risk for arrhythmias
  • 8.  38- For adults with septic shock on norepinephrine with inadequate MAP level we suggest adding vasopressin instead of escalating the dose of norepinephrine. ( weak recommendation)  In ICU practice vasopressin usually started when the dose of norepinephrine is in the range of 0.25 – 0.5 ug/kg/min.  39- For adults with septic shock and inadequate MAP level despite norepinephrine and vasopressin we suggest adding epinephrine. (weak recommendation)  40- For adults with septic shock we suggest against using terlipressin. (weak recommendation)
  • 9.  41- For adults with septic shock and cardiac dysfunction with persistent hypoperfusion despite adequate volume state and arterial blood pressure we suggest either adding dobutamine to norepinephrine or using epinephrine alone. (weak recommendation)  42- For adults with septic shock and cardiac dysfunction with persistent hypoperfusion despite adequate volume status and arterial blood pressure we suggest against using levosimendan. (weak recommendation)
  • 10. Monitoring and intravenous access  43- For adults with septic shock we suggest using invasive monitoring of arterial pressure over non invasive monitoring. (weak recommendation)  44- For adults with septic shock we suggest starting vasopressors peripherally to restore MAP rather than delaying initiation until a central access is secured. (weak recommendation)  Notes : When using vasopressors peripherally they should be administered only for short period of time and in a vein in or proximal to the antecubital fossa ..